EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?

Kevin Yau, Heather N Reich

Nephrology Dialysis Transplantation · 2026

DOI: 10.1093/ndt/gfaf135 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Kevin Yau und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University Health Network, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Inflammation, Anti-Inflammatory Agents, Kidney Glomerulus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Toronto Department of Medicine Eliot Phillipson Clinician Scientist Training Program, Clarence Henry Trelford Clinician Scientist Award in Diabetes, Health Data Research Network Canada Pragmatic Trials Training Program and a Kidney Research Scientist Core Education and National Training.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. The pathogenesis of IgAN is complex, characterized by gut mucosa–kidney interactions that lead to the production of galactose-deficient IgA1 and formation of immune complexes with antiglycan antibodies. Both arms of the adaptive and innate immune system are implicated in modifying or amplifying inflammatory cascades that lead to disease progression. Thus, altering the disease trajectory in IgAN requires therapies that target these underlying inflammatory processes. Broad immunosuppression, including systemic or locally gut mucosa–delivered corticosteroids and mycophenolate mofetil, have demonstrated efficacy in reducing proteinuria, although these are tempered by the risk of adverse effects. More recently, targeted treatment approaches at specific pathways, including complement inhibition and BAFF and/or APRIL inhibitors, have demonstrated promise and are under evaluation. Our ability to measure the degree of glomerular inflammation and predict response to treatment remains limited. To date, the IgA International Risk Prediction Tool remains the gold standard for the prediction of up to 5-year kidney outcomes guided by clinical criteria including proteinuria, estimated glomerular filtration rate and histologic criteria through the MEST-C score. With multiple potential emerging treatments, there is a need for validated biomarkers that reflect the degree of inflammation or IgAN disease activity that may facilitate personalized treatment strategies and improve long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGAInflammationAnti-Inflammatory AgentsKidney GlomerulusHumansGlomerular Filtration Rate

Stichwörter der Autor:innen

IgA nephropathyglomerularinflammation

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Division of Nephrology, University Health Network, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Toronto General Hospital Research Institute, Toronto, ON, Canada.

Förderung

  • University of Toronto Department of Medicine Eliot Phillipson Clinician Scientist Training Program
  • Clarence Henry Trelford Clinician Scientist Award in Diabetes
  • Health Data Research Network Canada Pragmatic Trials Training Program and a Kidney Research Scientist Core Education and National Training
  • Program Postdoctoral Fellowship
  • Canadian Society of Nephrology
  • Baxter-Oreopoulos Chair in Nephrology at the Temerty Faculty of Medicine

Zitieren

APA

Yau, K., & Reich, H. N. (2026). How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf135

Vancouver

Yau K, Reich HN. How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf135

BibTeX
@article{Yau2026,
  author = {Yau, Kevin and Reich, Heather N},
  title = {How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfaf135}
}
Kostenlos starten →